Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (1141-1150 of 1,389) with videos related to

Pageof 139
Sort By:
Medcomm|September 24, 2025
A Combined Model Based on Bone Mineral Density for Noninvasive Prediction of Prognosis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Retrospective StudyBingxin Gong, Yusheng Guo, Qi Wan, et al.
Medcomm|August 5, 2025
Nanoparticle-Delivered siRNA Targeting NSUN4 Relieves Systemic Lupus Erythematosus through Declining Mitophagy-Mediated CD8+T Cell ExhaustionBincheng Ren, Kaini He, Ning Wei, et al.
Medcomm|August 5, 2025
Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)/microRNA-302a-3p (miR-302a-3p)/ATPase Copper Transporting Beta (ATP7B) AxisChuyu Wang, Hao Wang, Chong Wang, et al.
Medcomm|September 10, 2025
Is <i>CABP2</i>-Associated Hearing Loss (DFNB93) a Gene Therapy Target? Preclinical Progress and Patient RegistryBarbara Vona, Bernd Wollnik, Nicola Strenzke, et al.
Medcomm|August 11, 2025
Molecular Mechanisms of Chronic Pain and Therapeutic InterventionsZhen Li, Xing Li, Jieqiong Liu, et al.
Medcomm|August 5, 2025
The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in ChinaYanan Zhou, Junbin Wang, Ranran Cao, et al.
Medcomm|September 22, 2025
Correction to "Depletion of Fat Mass and Obesity-Associated Protein (FTO) Drives Heterochromatin Loss via Lysine Acetyltransferase 8 (KAT8)-Mediated Remodeling and Spacing Factor 1 (RSF1) Acetylation in Skin Aging"
Medcomm|July 29, 2025
Polypharmacology-Driven Discovery of ZAK-I-57: A Potent Multi-Targeted Benzoxazinone Small Molecule for Hepatocellular Carcinoma TherapyShakeel Ahmad Khan, Huihai Yang, Fan Ying, et al.
Medcomm|July 14, 2025
Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic TargetsYutao Li, Qingyun Liu, Xilin Jing, et al.
Medcomm|July 21, 2025
Astrocyte in Neurological Disease: Pathogenesis and TherapyMeihui Huang, Aoyang Long, Lingjia Hao, et al.
Pageof 139

Showing results (1141-1150 of 1,389) with videos related to

Sort By:
Pageof 139
Medcomm|September 24, 2025
A Combined Model Based on Bone Mineral Density for Noninvasive Prediction of Prognosis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Retrospective StudyBingxin Gong, Yusheng Guo, Qi Wan, et al.
Medcomm|August 5, 2025
Nanoparticle-Delivered siRNA Targeting NSUN4 Relieves Systemic Lupus Erythematosus through Declining Mitophagy-Mediated CD8+T Cell ExhaustionBincheng Ren, Kaini He, Ning Wei, et al.
Medcomm|August 5, 2025
Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)/microRNA-302a-3p (miR-302a-3p)/ATPase Copper Transporting Beta (ATP7B) AxisChuyu Wang, Hao Wang, Chong Wang, et al.
Medcomm|September 10, 2025
Is <i>CABP2</i>-Associated Hearing Loss (DFNB93) a Gene Therapy Target? Preclinical Progress and Patient RegistryBarbara Vona, Bernd Wollnik, Nicola Strenzke, et al.
Medcomm|August 11, 2025
Molecular Mechanisms of Chronic Pain and Therapeutic InterventionsZhen Li, Xing Li, Jieqiong Liu, et al.
Medcomm|August 5, 2025
The Biological Characteristics and Mouse Model of Lassa Virus From the First Imported Case in ChinaYanan Zhou, Junbin Wang, Ranran Cao, et al.
Medcomm|September 22, 2025
Correction to "Depletion of Fat Mass and Obesity-Associated Protein (FTO) Drives Heterochromatin Loss via Lysine Acetyltransferase 8 (KAT8)-Mediated Remodeling and Spacing Factor 1 (RSF1) Acetylation in Skin Aging"
Medcomm|July 29, 2025
Polypharmacology-Driven Discovery of ZAK-I-57: A Potent Multi-Targeted Benzoxazinone Small Molecule for Hepatocellular Carcinoma TherapyShakeel Ahmad Khan, Huihai Yang, Fan Ying, et al.
Medcomm|July 14, 2025
Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic TargetsYutao Li, Qingyun Liu, Xilin Jing, et al.
Medcomm|July 21, 2025
Astrocyte in Neurological Disease: Pathogenesis and TherapyMeihui Huang, Aoyang Long, Lingjia Hao, et al.
Pageof 139